Breaking News Instant updates and real-time market news.

GM

General Motors

$39.75

(0.00%)

, SFTBY

SoftBank; also use SFTBF

$0.00

(0.00%)

10:14
07/10/18
07/10
10:14
07/10/18
10:14

RBC sees Cruise eventually being worth about as much as all of GM is now

This morning, RBC Capital analyst Joseph Spak raised his price target for General Motors (GM) to $53 citing the company's robo-taxi opportunity, as he believes Cruise could be worth nearly as much as GM today, even under modest assumptions. The analyst also argued that Softbank's (SFTBY) $2.25B investment adds validation to the autonomous driving unit. CRUISE OPPORTUNITY: In a research note to investors, RBC Capital analyst Joseph Spak raised his price target for General Motors to $53 from $52, while reiterating an Outperform rating on the shares. If successful, the analyst believes GM Cruise could be worth almost as much as General Motors today, even under modest assumptions. Assuming the company gets the tech right, Spak's scenario shows a fleet of about 800k vehicles driving 58B miles by 2030. At 55c/mile, he sees about $17B of EBITDA, with his estimate valuing Cruise's transportation network company at around $43B. The analyst also noted that he estimates shared autonomous vehicles or "robo-taxis" could be a $3.8T total addressable market by 2050. Furthermore, Spak told investors he sees the recent Softbank investment as adding validation as it provides capital to reach scale, affords GM capital allocation flexibility, validates Cruise's technology, progress and opportunity, and unlocks GM's share price value as Cruise is about $7 per share. Additionally, and while not forecasting a downturn, Spak has greater confidence in downside protection. The analyst believes uncertainty around downturn performance has been a contributing factor weighing on the multiple of GM shares, but thinks investors' overly pessimistic view should begin to fade. PRICE ACTION: In morning trading, shares of General Motors are fractionally higher at $39.88 per share.

GM

General Motors

$39.75

(0.00%)

SFTBY

SoftBank; also use SFTBF

$0.00

(0.00%)

  • 10

    Sep

GM General Motors
$39.75

(0.00%)

07/10/18
RBCM
07/10/18
NO CHANGE
Target $53
RBCM
Outperform
General Motors price target raised to $53 at RBC Capital
RBC Capital analyst Joseph Spak kept his Outperform rating on General Motors (GM) and nudged his price target to $53 from $52, saying the recent $2.25B investment by Softbank (SFTBF) adds validation to the company's GM Cruise robo-taxi offering plans. Aside from the validation, Spak notes that the investment "provides capital to reach scale commercialization, affords GM capital allocation flexibility, and unlocks GM share price value as Cruise around $7 per share."
06/18/18
NORL
06/18/18
NO CHANGE
Target $15
NORL
Outperform
TeleNav integration at GM a 'strong sign' of coming ramp-up, says Northland
Northland analyst Michael Latimore said he believes TeleNav (TNAV) is now integrated with General Motors' (GM) electronic data interchange system, which he views as "another strong sign" that GM plans to ramp sales of vehicles with TeleNav's system by the end of 2018. Latimore keeps an Outperform rating and $15 price target on TeleNav shares.
06/18/18
SBSH
06/18/18
NO CHANGE
SBSH
Buy
GM news supports $134 per share long-term upside case, says Citi
Bloomberg reported on Friday that General Motors has begun the process of contemplating strategic options for its Cruise AV division, Citi analyst Itay Michaeli tells investors in a research note. The analyst believes the news supports his long-term upside case of $134 for GM shares.
06/06/18
MSCO
06/06/18
NO CHANGE
MSCO
Morgan Stanley says Softbank stake in Cruise significant 'far beyond' just GM
Morgan Stanley analyst Adam Jonas said Softbank's (SFTBF) recently announced investment in GM Cruise "carries significance far beyond" General Motors (GM), arguing that the increasingly conspicuous involvement of "outside validators" such as large-cap tech firms and prominent investors can accelerate perception change in the capital markets about "Auto 2.0." He envisions the possible formation of two different companies currently held under one automaker's roof, which he dubs an Auto 2.0 "Yieldco" and an Auto 2.0 "Growthco." Converting car owners into monthly subscribers could open up significant revenue, profit, and value opportunities for traditional automakers, argues Jonas in a note to investors. Other automaking "OEMs" include Ford (F), Daimler (DDAIF), Toyota (TM), Honda (HMC), Fiat Chrysler (FCAU) and BMW Group (BAMXY).
SFTBY SoftBank; also use SFTBF
$0.00

(0.00%)

06/01/18
JPMS
06/01/18
NO CHANGE
Target $58
JPMS
Overweight
General Motors price target raised to $58 from $55 at JPMorgan
JPMorgan analyst Ryan Brinkman raised his price target for General Motors (GM) to $58 saying the $2.25B investment by SoftBank (SFTBY) in the company's Cruise autonomous mobility business is "positive on a number of fronts." The investment "puts a stake in the ground relative to the value of Cruise" and shows "just how inexpensive GM's core automotive operations really are," Brinkman tells investors in a research note. The analyst sees 36% upside in shares of GM and reiterates an Overweight rating on the name.
11/06/17
SBSH
11/06/17
NO CHANGE
Target $75
SBSH
Buy
Citi trims T-Mobile, Sprint targets after merger talks cease
Citi analyst Michael Rollins lowered his price target for Buy-rated T-Mobile (TMUS) to $75 from $77 and for Neutral-rated Sprint (S) to $7.50 from $9.00 after the companies ceased talks to merge. He sees T-Mobile as "very comfortable" with its operating momentum and improving financial position and SoftBank (SFTBY) and Sprint (S) taking a more aggressive posture to pursue strategic partners. The analyst would not be surprised if SoftBank and Deutsche Telekom (DTEGY) revisit the merger talks in 6-12 months should Sprint and T-Mobile not find compelling strategic partners. Further, Rollins expects tower stocks like American Tower (AMT), SBA Communications (SBAC) and Crown Castle (CCI) to trade higher on expectations for greater capital expenditures now that the merger talks are over.
08/16/17
SBSH
08/16/17
NO CHANGE
SBSH
Citi still views Sprint, T-Mobile merger as most likely
Citi analysts Michael Rollins and Jason Bazinet continue to expect 2017 to be the year of mergers and acquisitions in the Wireless space. Since attending SoftBank's (SFTBY) Q2 Investor event and meeting with T-Mobile US (TMUS) management, the analysts still view a merger scenario between Sprint (S) and T-Mobile as the most likely to emerge in the Wireless space. "We are getting the increasing sense from multiple companies in the category that the regulatory environment may be as good as it gets," Rollins and Bazinet write in a research note.
07/31/17
JPMS
07/31/17
NO CHANGE
Target $450
JPMS
Overweight
Charter offer would likely have to be at least $500 per share, says JPMorgan
JPMorgan analyst Philip Cusick believes SoftBank (SFTBY) is one of the few companies that could offer a big enough price to take control of Charter Communications (CHTR). While a deal is not very likely, Softbank Chairman Masayoshi Son "is never to be counted out as a buyer," Cusick tells investors in a research note. He believes a Charter acquisition offer would likely have to be in the $500 per share or higher range. Charter shares in premarket trading are up $31.74 to $402 after the Wall Street Journal reported Friday night that SoftBank has interest in merging the company with Sprint. Cusick estimates annual synergies between Sprint (S) and Charter could be around $2B, with minimal cost to integrate versus a Sprint and T-Mobile (TMUS) merger "which would have more eventual cost savings but cost much more to integrate." A Sprint and Charter deal would not have a difficult regulatory review, the analyst believes. Cusick adds that if Charter looked like it was going to sell to Softbank, Comcast (CMCSA) would have to decide if it ever did want to buy Charter and "move more quickly with an even bigger premium."

TODAY'S FREE FLY STORIES

ITCI

Intra-Cellular

$15.34

0.23 (1.52%)

07:13
12/11/18
12/11
07:13
12/11/18
07:13
Hot Stocks
Intra-Cellular announces FDA accepts lumateperone NDA for review »

Intra-Cellular announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$255.25

-3.32 (-1.28%)

07:13
12/11/18
12/11
07:13
12/11/18
07:13
Conference/Events
Domino's Pizza management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 14

    Dec

DSW

DSW

$23.04

-1.19 (-4.91%)

07:12
12/11/18
12/11
07:12
12/11/18
07:12
Hot Stocks
Breaking Hot Stocks news story on DSW »

DSW up 16.7% to $27.00…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TSN

Tyson Foods

$55.42

-0.78 (-1.39%)

07:12
12/11/18
12/11
07:12
12/11/18
07:12
Initiation
Tyson Foods initiated  »

Tyson Foods reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

DSW

DSW

$23.04

-1.19 (-4.91%)

07:11
12/11/18
12/11
07:11
12/11/18
07:11
Hot Stocks
DSW says ends Q3 with inventories of $624M »

The company ended the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NMIH

NMI Holdings

$18.14

-0.17 (-0.93%)

07:10
12/11/18
12/11
07:10
12/11/18
07:10
Initiation
NMI Holdings initiated  »

NMI Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$23.04

-1.19 (-4.91%)

07:09
12/11/18
12/11
07:09
12/11/18
07:09
Earnings
Breaking Earnings news story on DSW »

DSW: Camuto Group to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

GNL

Global Net Lease

07:09
12/11/18
12/11
07:09
12/11/18
07:09
Initiation
Global Net Lease initiated  »

Global Net Lease…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRBK

Green Brick

$8.01

0.02 (0.25%)

07:09
12/11/18
12/11
07:09
12/11/18
07:09
Initiation
Green Brick initiated  »

Green Brick initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPTN

Optinose

$8.01

-0.07 (-0.87%)

07:08
12/11/18
12/11
07:08
12/11/18
07:08
Hot Stocks
Optinose, Avanir Pharmaceuticals to terminate Onzetra Xsail license agreement »

Optinose announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

STML

Stemline

$10.36

0.38 (3.81%)

07:07
12/11/18
12/11
07:07
12/11/18
07:07
Initiation
Stemline initiated  »

Stemline initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DSW

DSW

$23.04

-1.19 (-4.91%)

07:07
12/11/18
12/11
07:07
12/11/18
07:07
Earnings
DSW sees Q4 EPS excluding Camuto Group 1c-11c, consensus 19c »

Sees Q4 EPS including…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

WPP

WPP

$51.13

-0.98 (-1.88%)

07:06
12/11/18
12/11
07:06
12/11/18
07:06
Earnings
WPP expects to report FY18 results in line with consensus estimates »

WPP provided the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

FBK

FB Financial

$35.66

-0.17 (-0.47%)

07:06
12/11/18
12/11
07:06
12/11/18
07:06
Initiation
FB Financial initiated  »

FB Financial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENB

Enbridge

$31.40

-0.54 (-1.69%)

, SEP

Spectra Energy Partners

$34.83

-0.6 (-1.69%)

07:05
12/11/18
12/11
07:05
12/11/18
07:05
Hot Stocks
Enbridge making progress on buy-in of interest in Sponsored Vehicles »

Enbridge (ENB) continues…

ENB

Enbridge

$31.40

-0.54 (-1.69%)

SEP

Spectra Energy Partners

$34.83

-0.6 (-1.69%)

EEP

Enbridge Energy

$10.47

-0.18 (-1.69%)

EEQ

Enbridge Energy Management

$10.48

-0.16 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SPN

Superior Energy

$4.14

-0.15 (-3.50%)

07:05
12/11/18
12/11
07:05
12/11/18
07:05
Downgrade
Superior Energy rating change  »

Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$12.46

0.35 (2.89%)

07:05
12/11/18
12/11
07:05
12/11/18
07:05
Hot Stocks
Athenex announces results from second cohort of Oraxol plus ramucirumab trial »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENB

Enbridge

$31.40

-0.54 (-1.69%)

07:05
12/11/18
12/11
07:05
12/11/18
07:05
Hot Stocks
Enbridge announces $1.8B of new accretive growth capital investments »

Enbridge is announcing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NBR

Nabors Industries

$2.76

-0.33 (-10.68%)

07:04
12/11/18
12/11
07:04
12/11/18
07:04
Downgrade
Nabors Industries rating change  »

Nabors Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

HCP

HCP

$29.81

-0.06 (-0.20%)

07:04
12/11/18
12/11
07:04
12/11/18
07:04
Syndicate
HCP 15M share Spot Secondary priced at $28.90 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

DSW

DSW

$23.04

-1.19 (-4.91%)

07:04
12/11/18
12/11
07:04
12/11/18
07:04
Hot Stocks
Breaking Hot Stocks news story on DSW »

DSW lowers FY18 tax rate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ENB

Enbridge

$31.40

-0.54 (-1.69%)

07:04
12/11/18
12/11
07:04
12/11/18
07:04
Hot Stocks
Enbridge still sees 2018 DCF per share in upper half of $4.15-$4.45 range »

Enbridge continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ENB

Enbridge

$31.40

-0.54 (-1.69%)

07:03
12/11/18
12/11
07:03
12/11/18
07:03
Hot Stocks
Enbridge reaffirms 10% annual growth guidance through 2020 »

Enbridge announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

DSW

DSW

$23.04

-1.19 (-4.91%)

07:03
12/11/18
12/11
07:03
12/11/18
07:03
Earnings
DSW raises FY18 adjusted EPS view to $1.70-$1.85 from $1.60-$1.75 »

FY18 consensus $1.72.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BLRX

BioLineRx

$0.66

0.005 (0.76%)

07:03
12/11/18
12/11
07:03
12/11/18
07:03
Hot Stocks
BioLineRx begins triple combination arm of the Phase 2a COMBAT/KEYNOTE-202 study »

BioLineRx announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.